1. DNA Repair Pathway Alterations in Bladder Cancer
   Kent Mouw, 2017, Cancers CrossRef
2. The roles of excision repair cross-complementation group1 in objective response after cisplatin-based concurrent chemoradiotherapy and survival in head and neck cancers: A systematic review and meta-analysis
   Yang Gao et al, 2015, Oral Oncology CrossRef
3. Heterogeneity of excision repair cross-complementation group 1 gene expression in non-small-cell lung cancer patients
   SERHEY SMIRNOV et al, 2015 CrossRef
4. Not breathing is not an option: How to deal with oxidative DNA damage
   Enni Markkanen, 2017, DNA Repair CrossRef
5. ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinum based chemotherapy: A systematic review and meta-analysis
   Yuksel Urun et al, 2017, Critical Reviews in Oncology/Hematology CrossRef
6. null
   Ryan Hutchinson et al, 2018 CrossRef
7. XRCC1 Arg399Gln Gene Polymorphism and Hepatocellular Carcinoma Risk in the Italian Population
   Concetta Santonocito et al, 2017, The International Journal of Biological Markers CrossRef
8. Biomarkers for Predicting Clinical Outcomes of Chemoradiation-Based Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer
   Fumitaka Koga et al, 2018, IJMS CrossRef
9. Molecular biomarkers in bladder preservation therapy for muscle-invasive bladder cancer
   David T Miyamoto et al, 2018, The Lancet Oncology CrossRef
10. Hope and challenge: Precision medicine in bladder cancer
    Hongwei Su et al, 2019, Cancer Med CrossRef
11. ERCC1 expression and tumor regression predict survival in esophageal squamous cell carcinoma patients receiving combined trimodality therapy
    Hong Ge et al, 2014, Pathology - Research and Practice CrossRef
12. ERCC1 as a Prognostic and Predictive Biomarker for Urothelial Carcinoma of the Bladder following Radical Cystectomy
    Tobias Klatte et al, 2015, Journal of Urology CrossRef
13. Predictive and prognostic values of ERCC1 and XRCC1 in biliary tract cancers
    Muhtashim Mian et al, 2016, J Clin Pathol CrossRef
14. DNA base excision repair proteins APE-1 and XRCC-1 are overexpressed in oral tongue squamous cell carcinoma
    Thalita Santana et al, 2017, J Oral Pathol Med CrossRef
15. Bladder-sparing treatment options in localized muscle-invasive bladder cancer.
    Gregory J Nason et al, 2020, Expert Rev Anticancer Ther CrossRef
16. XRCC1 Is a Promising Predictive Biomarker and Facilitates Chemo-Resistance in Gallbladder Cancer
    Zhengchun Wu et al, 2020, Front. Mol. Biosci. CrossRef
17. Diagnostic and Prognostic Potential of Biomarkers CYFRA 21.1, ERCC1, p53, FGFR3 and TATI in Bladder Cancers
    Milena Matuszczak et al, 2020, IJMS CrossRef
18. Emerging biomarkers in urothelial carcinoma: challenges and opportunities
    Nikolaos Andreatos et al, 2020, Cancer Treatment and Research Communications CrossRef
19. Clinical Perspectives of ERCC1 in Bladder Cancer
    Konstantinos Koutsoukos et al, 2020, IJMS CrossRef
20. Bladder preservation: Translating discovery for clinical impact in urothelial cancer
    David T. Miyamoto et al, 2020, Urologic Oncology: Seminars and Original Investigations CrossRef
21. Bladder Cancer Tissue-Based Biomarkers
    Francesco Soria et al, 2021 CrossRef
22. Will the Use of Biomarkers Improve Bladder Cancer Radiotherapy Delivery?
    A.A. Solanki et al, 2021, Clinical Oncology CrossRef
23. Significant Association Between XRCC1 Expression and Its rs25487 Polymorphism and Radiotherapy-Related Cancer Prognosis
    Li Gong et al, 2021, Front. Oncol. CrossRef
24. null
    Fiona Wilson et al, 2022 CrossRef
25. Novel Candidate Biomarkers of Chemoradiosensitivity in Esophageal Squamous Cell Carcinoma: A Systematic Review
    Yusuke Sato et al, 2016, Eur Surg Res CrossRef
26. Impact of Programmed Death-ligand 1 Expression on Oncological Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Radiation-based Therapy
    Gautier Marcq et al, 2022, European Urology Open Science CrossRef
27. Primary Intracranial Ewing Sarcoma Invading the Superior Sagittal Sinus with EWSR1-FLI1 Gene Fusion and EWSR1 Gene Mutation: A Case Report and Literature Review
    Ziang Geng et al, 2023, World Neurosurgery CrossRef
28. Biomarkers determining treatment tactics in metastatic urothelial cancer
    L. Yu. Grivtsova et al, 2023, Onkourologiâ CrossRef